Chorea Gravidarum

Chorea Gravidarum

Overview

Chorea gravidarum is a rare movement disorder characterized by involuntary, irregular, jerky movements that occur during pregnancy. The term literally means "chorea of pregnancy" and represents a form of chorea that emerges in women during gestation, typically in the second or third trimester[@gomes2020]. This condition is not a single disease but rather a manifestation of various underlying disorders that become symptomatic during pregnancy due to hormonal, metabolic, and immunological changes[@speelman2019].

The disorder was more commonly diagnosed in the pre-antibiotic era when rheumatic fever was prevalent. Today, it is encountered much less frequently due to improved treatment of streptococcal infections and rheumatic heart disease, though it remains an important diagnostic consideration in pregnant women presenting with abnormal movements[@walker2021].

Epidemiology

Chorea gravidarum is a rare condition, estimated to affect approximately 1 in every 2,000-5,000 pregnancies[@gomes2020]. The peak incidence occurs in primigravidae (first-time pregnant women) between the ages of 20 and 30 years[@speelman2019]. The condition typically appears during the second or third trimester, though it can present as early as the first trimester in some cases[@walker2021].

Chorea Gravidarum

Overview

Chorea gravidarum is a rare movement disorder characterized by involuntary, irregular, jerky movements that occur during pregnancy. The term literally means "chorea of pregnancy" and represents a form of chorea that emerges in women during gestation, typically in the second or third trimester[@gomes2020]. This condition is not a single disease but rather a manifestation of various underlying disorders that become symptomatic during pregnancy due to hormonal, metabolic, and immunological changes[@speelman2019].

The disorder was more commonly diagnosed in the pre-antibiotic era when rheumatic fever was prevalent. Today, it is encountered much less frequently due to improved treatment of streptococcal infections and rheumatic heart disease, though it remains an important diagnostic consideration in pregnant women presenting with abnormal movements[@walker2021].

Epidemiology

Chorea gravidarum is a rare condition, estimated to affect approximately 1 in every 2,000-5,000 pregnancies[@gomes2020]. The peak incidence occurs in primigravidae (first-time pregnant women) between the ages of 20 and 30 years[@speelman2019]. The condition typically appears during the second or third trimester, though it can present as early as the first trimester in some cases[@walker2021].

Historical data from the early 20th century suggest that chorea gravidarum accounted for a significant proportion of movement disorders in pregnancy. Modern series are limited given the rarity of the condition, but available evidence suggests the incidence has decreased substantially since the advent of antibiotics and improved maternal healthcare[@piccoli2018].

Pathophysiology

The pathophysiology of chorea gravidarum is multifactorial and relates to the complex physiological changes of pregnancy that unmask or exacerbate underlying neurological conditions[@speelman2019]:

Hormonal Changes

Pregnancy induces significant changes in sex hormones, particularly estrogen and progesterone. These hormones can modulate dopamine receptor sensitivity and alter neurotransmitter metabolism in the basal ganglia[@walker2021]. Estrogen has been shown to increase dopamine receptor density in striatal regions, potentially contributing to hyperkinetic movements.

Rheumatic Fever Association

In many historical cases, chorea gravidarum was linked to prior rheumatic fever, particularly Sydenham chorea that remitted and then recurred during pregnancy[@gomes2020]. The immunological cross-reactivity between streptococcal antigens and neuronal tissue (molecular mimicry) leads to basal ganglia dysfunction that can be reactivated by the immunological stress of pregnancy.

Metabolic Factors

Pregnancy creates a state of relative immune suppression followed by rebound immune activation. This immunological turbulence can trigger autoimmune phenomena affecting the central nervous system[@speelman2019]. Additionally, the hypercoagulable state of pregnancy may contribute to microvascular changes in the basal ganglia.

Genetic Predisposition

Some cases appear to represent new-onset chorea in women with underlying genetic susceptibility, such as mutations in genes associated with familial choreas (e.g., [HTT](/proteins/huntingtin) for Huntington disease, ATP1A3 for alternating hemiplegia of childhood)[@walker2021].

Clinical Features

Core Symptoms

The characteristic movement disorder consists of involuntary, irregular, jerky movements that are randomly distributed throughout the body[@gomes2020]. These movements:

• Are non-rhythmic and purposeless
• Vary in intensity from subtle twitches to severe, continuous motions
• May involve the face (grimacing, tongue protrusion), limbs (fidgeting movements), and trunk (twisting motions)
• Typically disappear during sleep
• May be exacerbated by voluntary activity or emotional stress

Associated Features

• Psychiatric symptoms: Anxiety, depression, emotional lability, and rarely psychosis[@speelman2019]
• Motor weakness: Some patients develop generalized weakness or paresis
• Cognitive changes: Mild cognitive impairment may be present
• Gait disturbance: Walking may become unsteady due to truncal chorea

Disease Course

Symptoms typically develop gradually over days to weeks[@walker2021]. In most cases, chorea gravidarum is self-limited and resolves within weeks to months after delivery. However, recurrence in subsequent pregnancies is common, and some women may develop persistent movement disorders[@piccoli2018].

Causes and Risk Factors

Primary Associations

Precipitating Factors

• First pregnancy
• Multiple gestation
• History of rheumatic heart disease
• Family history of movement disorders
• Autoimmune disorders

Diagnosis

Clinical Assessment

Diagnosis is primarily clinical, based on the characteristic movement disorder occurring during pregnancy[@gomes2020]. A thorough history should include:

• Prior history of chorea or rheumatic fever
• Family history of neurological disorders
• Gestational age at onset
• Associated symptoms

Laboratory Investigations

Initial workup[@speelman2019][@walker2021]:

• Complete blood count
• Comprehensive metabolic panel (including electrolytes, glucose, liver function)
• Thyroid function tests
• Anti-streptolysin O titer (ASO)
• Antinuclear antibody (ANA)
• Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, anti-β2-glycoprotein I)
• Syphilis serology (historically associated)

Neuroimaging

• MRI brain: Recommended to exclude structural lesions, stroke, or basal ganglia abnormalities[@walker2021]
• CT scan: May be useful in acute settings to rule out hemorrhage

Genetic Testing

Consider genetic counseling and testing for Huntington disease or other hereditary choreas when onset is atypical or there is a family history[@speelman2019].

Differential Diagnosis

| Condition | Key Features |
|------------|---------------|
| Sydenham chorea | Usually pre-pubertal, associated with rheumatic fever |
| Huntington disease | Progressive, family history, cognitive decline |
| Wilson disease | Kayser-Fleischer rings, liver disease |
| Antiphospholipid syndrome | Thrombosis, pregnancy loss, thrombocytopenia |
| Drug-induced chorea | Temporal relation to medications |
| Thyrotoxicosis | Weight loss, tachycardia, heat intolerance |

Treatment

General Principles

Treatment must balance the severity of movements with the safety of the fetus[@gomes2020][@walker2021]:

• Mild cases: Often require only observation and supportive care
• Moderate to severe cases: Pharmacological intervention may be necessary

Pharmacological Management

First-line agents[@speelman2019]:

• Benzodiazepines (e.g., diazepam, lorazepam): May be used for mild to moderate symptoms; use lowest effective dose
• Valproic acid: Effective for various choreas; weigh against neural tube defect risk in first trimester

• Tetrabenazine: Depletes dopamine; use with caution due to potential fetal effects
• Haloperidol: Dopamine receptor antagonist; reserved for severe cases
• Corticosteroids: May be considered if autoimmune etiology is suspected

Non-Pharmacological Approaches

• Supportive care: Safety measures to prevent injury from falls
• Physical therapy: May help maintain function and balance
• Psychological support: Address anxiety and depression

Delivery Planning

Most cases resolve after delivery[@gomes2020]. Planning for delivery should include:

• Neurological consultation
• Anesthesia assessment (if cesarean section is needed)
• Postpartum follow-up

Prognosis

Maternal Outcomes

The prognosis for chorea gravidarum is generally favorable[@walker2021]:

• Most women experience complete resolution within weeks to months postpartum
• Recurrence in subsequent pregnancies occurs in up to 50% of cases
• Some women develop persistent mild chorea
• Mortality is rare with appropriate management

Fetal Outcomes

With modern management, fetal outcomes are generally good[@speelman2019]:

• Increased risk of intrauterine growth restriction in severe cases
• Potential for preterm delivery in some cases
• No known direct teratogenic effects of the chorea itself

Related Conditions

• [Sydenham chorea](/diseases/sydenham-chorea) - Post-streptococcal autoimmune chorea
• [Huntington disease](/diseases/huntington-disease) - Genetic neurodegenerative chorea
• [Benign hereditary chorea](/diseases/benign-hereditary-chorea) - Non-progressive familial chorea
• [Hemiballismus](/diseases/hemiballismus) - Acute violent choreic movement
• [Hemichorea](/diseases/hemichorea) - Unilateral chorea

See Also

• [Sydenham chorea](/diseases/sydenham-chorea)
• [Huntington disease](/diseases/huntington-disease)
• [Benign hereditary chorea](/diseases/benign-hereditary-chorea)
• [Hemiballismus](/diseases/hemiballismus)
• [Hemichorea](/diseases/hemichorea)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

Recent Research (2024-2026)

Recent research on Chorea Gravidarum includes:

• 2024: [Title](https://pubmed.ncbi.nlm.nih.gov/XXXXX/) - Description

References